Lanean...

Ticagrelor-Induced Prolongation of the QTc Interval

BACKGROUND: Ticagrelor has been accepted as a class I antiplatelet agent in patients undergoing percutaneous coronary angioplasty (PTCA). There have been cases reported on ticagrelor being associated with various cardiac conduction defects. But there is no evidence of QTc prolongation associated wit...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Case Rep Cardiol
Egile Nagusiak: Ray, Avik, Najmi, Ahmad, Khandelwal, Gaurav, Sadasivam, Balakrishnan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi 2019
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6881594/
https://ncbi.nlm.nih.gov/pubmed/31827937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/5984847
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!